• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒奥密克戎变异株 BA.4/BA.5 刺突突变导致近期接种疫苗个体 T 细胞逃逸。

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.

机构信息

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.

Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands.

出版信息

Viruses. 2022 Dec 29;15(1):101. doi: 10.3390/v15010101.

DOI:10.3390/v15010101
PMID:36680141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863717/
Abstract

SARS-CoV-2 Omicron (B.1.1.529) lineages rapidly became dominant in various countries reflecting its enhanced transmissibility and ability to escape neutralizing antibodies. Although T cells induced by ancestral SARS-CoV-2-based vaccines also recognize Omicron variants, we showed in our previous study that there was a marked loss of T cell cross-reactivity to spike epitopes harboring Omicron BA.1 mutations. The emerging BA.4/BA.5 subvariants carry other spike mutations than the BA.1 variant. The present study aims to investigate the impact of BA.4/BA.5 spike mutations on T cell cross-reactivity at the epitope level. Here, we focused on universal T-helper epitopes predicted to be presented by multiple common HLA class II molecules for broad population coverage. Fifteen universal T-helper epitopes of ancestral spike, which contain mutations in the Omicron BA.4/BA.5 variants, were identified utilizing a bioinformatic tool. T cells isolated from 10 subjects, who were recently vaccinated with mRNA-based BNT162b2, were tested for functional cross-reactivity between epitopes of ancestral SARS-CoV-2 spike and the Omicron BA.4/BA.5 spike counterparts. Reduced T cell cross-reactivity in one or more vaccinees was observed against 87% of the tested 15 non-conserved CD4 T cell epitopes. These results should be considered for vaccine boosting strategies to protect against Omicron BA.4/BA.5 and future SARS-CoV-2 variants.

摘要

SARS-CoV-2 的奥密克戎(B.1.1.529)谱系迅速在各国占据主导地位,这反映了其增强的传染性和逃避中和抗体的能力。尽管基于原始 SARS-CoV-2 的疫苗诱导的 T 细胞也能识别奥密克戎变异株,但我们在之前的研究中表明,T 细胞对刺突表位的交叉反应性明显丧失,这些表位含有奥密克戎 BA.1 突变。新兴的 BA.4/BA.5 亚变异株携带的刺突突变与 BA.1 变异株不同。本研究旨在探讨 BA.4/BA.5 刺突突变对表位水平 T 细胞交叉反应性的影响。在这里,我们专注于预测由多种常见 HLA Ⅱ类分子呈递的通用 T 辅助表位,以实现广泛的人群覆盖。利用生物信息学工具,确定了原始刺突中包含奥密克戎 BA.4/BA.5 变异株突变的 15 个通用 T 辅助表位。从最近接种 mRNA 疫苗 BNT162b2 的 10 名受试者中分离 T 细胞,测试其与原始 SARS-CoV-2 刺突和奥密克戎 BA.4/BA.5 刺突对应物之间的表位的功能交叉反应性。在 15 个测试的非保守 CD4 T 细胞表位中,有 87%的疫苗接种者的 T 细胞交叉反应性降低。在针对奥密克戎 BA.4/BA.5 和未来 SARS-CoV-2 变异株的疫苗加强策略中应考虑这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/da5120cf9e62/viruses-15-00101-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/3fa9e16602a8/viruses-15-00101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/105393794963/viruses-15-00101-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/da5120cf9e62/viruses-15-00101-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/3fa9e16602a8/viruses-15-00101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/105393794963/viruses-15-00101-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d03/9863717/da5120cf9e62/viruses-15-00101-g003.jpg

相似文献

1
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.新冠病毒奥密克戎变异株 BA.4/BA.5 刺突突变导致近期接种疫苗个体 T 细胞逃逸。
Viruses. 2022 Dec 29;15(1):101. doi: 10.3390/v15010101.
2
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少,导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
3
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.疫苗衍生的 SARS-CoV-2 T 细胞反应对 BA.2.86 和 JN.1 的交叉反应性评估
Viruses. 2024 Mar 20;16(3):473. doi: 10.3390/v16030473.
4
Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.细胞表位景观显示逃避细胞免疫的 SARS-CoV-2 变体刺突的热点突变。
J Med Virol. 2024 Feb;96(2):e29452. doi: 10.1002/jmv.29452.
5
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.第三剂 COVID-19 mRNA 疫苗接种后针对奥密克戎变异株的持续 T 细胞介导的免疫应答。
Front Immunol. 2023 Jan 23;14:1099246. doi: 10.3389/fimmu.2023.1099246. eCollection 2023.
6
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.奥密克戎 BA.1 和 BA.2 中和抗体在 COVID-19 mRNA 疫苗接种者中的结构分析。
Nat Commun. 2022 Jun 13;13(1):3375. doi: 10.1038/s41467-022-31115-8.
7
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.BA.2.12.1、BA.4 和 BA.5 逃避奥密克戎感染诱导的抗体。
Nature. 2022 Aug;608(7923):593-602. doi: 10.1038/s41586-022-04980-y. Epub 2022 Jun 17.
8
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
9
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.鉴定和分析针对多种 SARS-CoV-2 变体具有中和活性的单克隆抗体。
J Virol. 2023 Jun 29;97(6):e0028623. doi: 10.1128/jvi.00286-23. Epub 2023 May 16.
10
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.SARS-CoV-2 奥密克戎变异株 BA.1 和 BA.2 中刺突感染力、加工和中和的决定因素。
Cell Host Microbe. 2022 Sep 14;30(9):1255-1268.e5. doi: 10.1016/j.chom.2022.07.006. Epub 2022 Jul 18.

引用本文的文献

1
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity.麻疹病毒T细胞表位的基因变异对疫苗诱导的T细胞免疫的影响。
NPJ Vaccines. 2025 Feb 20;10(1):36. doi: 10.1038/s41541-025-01088-y.
2
T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.新冠病毒JN.1逃逸株通过靶向两个细胞毒性T细胞表位热点实现T细胞免疫逃逸
Nat Immunol. 2025 Feb;26(2):265-278. doi: 10.1038/s41590-024-02051-0. Epub 2025 Jan 28.
3
Semi-Covariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Its Variants Omicron, BA.5, EG.5, and JN.1 for Viral Infectivity, Virulence and Immune Escape.

本文引用的文献

1
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.既往感染严重急性呼吸综合征冠状病毒2对奥密克戎BA.4和BA.5亚变体的保护作用。
N Engl J Med. 2022 Oct 27;387(17):1620-1622. doi: 10.1056/NEJMc2209306. Epub 2022 Oct 5.
2
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.二价含奥密克戎成分的新冠病毒加强疫苗。
N Engl J Med. 2022 Oct 6;387(14):1279-1291. doi: 10.1056/NEJMoa2208343. Epub 2022 Sep 16.
3
Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-2.
SARS-CoV-2 及其变异株奥密克戎、BA.5、EG.5 和 JN.1 的刺突蛋白的半协方差系数分析:病毒感染力、毒力和免疫逃逸。
Viruses. 2024 Jul 25;16(8):1192. doi: 10.3390/v16081192.
4
Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status.不同 COVID-19 疫苗引起的 T 细胞反应不同,以及与年龄和 CMV 状态相关的对 SARS-CoV-2 变体的交叉反应性。
Front Immunol. 2024 May 7;15:1392477. doi: 10.3389/fimmu.2024.1392477. eCollection 2024.
5
Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4 T cell clonotypes.二价 mRNA COVID 疫苗主要诱导交叉反应性 CD4 T 细胞克隆型。
Cell Rep Med. 2024 Mar 19;5(3):101442. doi: 10.1016/j.xcrm.2024.101442. Epub 2024 Feb 28.
6
COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood.COVID-19 疫苗诱导母血和脐血中针对 SARS-CoV-2 奥密克戎变异株的中和效价较低。
Front Immunol. 2023 Jul 3;14:1211558. doi: 10.3389/fimmu.2023.1211558. eCollection 2023.
7
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4 T-cell response with pre-primed responses directed against common cold coronaviruses.针对 SARS-CoV-2 NSP12 定向 CD4 T 细胞反应与针对普通感冒冠状病毒的预先存在反应的广泛交叉反应性的证据。
Front Immunol. 2023 May 5;14:1182504. doi: 10.3389/fimmu.2023.1182504. eCollection 2023.
8
HLA Variation and SARS-CoV-2 Specific Antibody Response.人类白细胞抗原变异与 SARS-CoV-2 特异性抗体应答。
Viruses. 2023 Mar 31;15(4):906. doi: 10.3390/v15040906.
包括BA.4和BA.5在内的奥密克戎亚变体基本保留了原始新冠病毒的T细胞表位。
Immune Netw. 2022 Aug 3;22(4):e29. doi: 10.4110/in.2022.22.e29. eCollection 2022 Aug.
4
Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors.SARS-CoV-1 幸存者对 COVID-19 加强疫苗的抗体和 T 细胞反应。
Clin Immunol. 2022 Nov;244:109103. doi: 10.1016/j.clim.2022.109103. Epub 2022 Aug 29.
5
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.奥密克戎 BA.4/BA.5 逃避由 BA.1 感染引起的中和抗体免疫。
Nat Commun. 2022 Aug 10;13(1):4686. doi: 10.1038/s41467-022-32396-9.
6
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.SARS-CoV-2 奥密克戎亚谱系表现出不同的抗体逃逸模式。
Cell Host Microbe. 2022 Sep 14;30(9):1231-1241.e6. doi: 10.1016/j.chom.2022.07.002. Epub 2022 Jul 7.
7
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少,导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
8
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.奥密克戎刺突功能和中和活性由一组全面的疫苗引发。
Science. 2022 Aug 19;377(6608):890-894. doi: 10.1126/science.abq0203. Epub 2022 Jul 19.
9
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.疫苗对 SARS-CoV-2 奥密克戎变异株增强的中和抗体迅速下降。
Cell Rep Med. 2022 Jul 19;3(7):100679. doi: 10.1016/j.xcrm.2022.100679. Epub 2022 Jun 20.
10
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection.三剂 BNT162b2 疫苗或 BA.1 感染对奥密克戎亚谱系和德尔塔克戎 SARS-CoV-2 的中和作用。
Emerg Microbes Infect. 2022 Dec;11(1):1828-1832. doi: 10.1080/22221751.2022.2099305.